LINAGLIPTIN METHYL DIMER

UNII:	2KBV5Y66DK
Type:	INGREDIENT SUBSTANCE
Formula:	C₅₁H₅₆N₁₆O₄
Preferred Substance Name:	LINAGLIPTIN METHYL DIMER
InChIKey:	RYJQYUJRKHESAR-KKLWWLSJSA-N
GSRS Full Record:	2KBV5Y66DK i

2463617-49-2
8-((R)-3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-1-((4-(2-(((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,Chemicalbook6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)amino)ethyl)quinazolin-2-yl)methyl)-3-methyl-3,7-dihydro-1H-purine-2,6-dione
8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-ynyl-1-[[4-[2-[[(3R)-1-[7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxopurin-8-yl]piperidin-3-yl]amino]ethyl]quinazolin-2-yl]methyl]-3-methylpurine-2,6-dione
Linagliptin Methyl Dimer

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LINAGLIPTIN METHYL DIMER

Synonyms and Mappings

Resources